Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
Katharine Margaret Irvine, Isanka Ratnasekera, Elizabeth E. Powell et al. · Frontiers in Immunology · 2019 · Review
Full textCC BY
Hepatology
Filters3 filters applied
Status
Year
Readable here
Study type
Licence
Corrected Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Mousumi Khatun, Ratna B. Ray · Cells · 2019 · Review
Full textCC BY
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Bedair Dewidar, Christoph Meyer, Steven Dooley et al. · Cells · 2019 · Review
Full textCC BY
Liver organoids: from basic research to therapeutic applications
Nicole Prior, Patricia Inacio, Meritxell Huch · Gut · 2019 · Review
Full textCC BY
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Renumathy Dhanasekaran, Salome Bandoh, Lewis R. Roberts · F1000Research · 2016 · Review
Full textCC BY
Orchestrating liver development
Miriam Gordillo, Todd Evans, Valerie Gouon-Evans · Development · 2015 · Review
Full textCC BY
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
Ming Liu, Lingxi Jiang, Xin-Yuan Guan · Protein & Cell · 2014 · Review
Abstract only
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany, David R. Nelson, Doris B. Strader et al. · Hepatology · 2011 · Review
Abstract only
Role of IL-17 and Th17 Cells in Liver Diseases
Linda Hammerich, Felix Heymann, Frank Tacke · Clinical and Developmental Immunology · 2011 · Review
Full textCC BY
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Jinsheng Guo, Scott L Friedman · Fibrogenesis & Tissue Repair · 2010 · Review
Full textCC BY